Literature DB >> 19580854

Immunohistochemical localisation of the creatine transporter in the rat brain.

C S W Mak1, H J Waldvogel, J R Dodd, R T Gilbert, M T J Lowe, N P Birch, R L M Faull, D L Christie.   

Abstract

Creatine (Cr) is required to maintain ATP levels in the brain. The transport of Cr across the blood-brain barrier and into neurones requires a specific creatine transporter (CRT). Mutations in the CRT gene (SLC6A8) result in a novel form of X-linked mental retardation, characterised by developmental delays, seizures and a complete absence of Cr from the brain. To identify cell types and regions that depend on Cr for energy metabolism we have determined the regional and cellular localisation of CRT protein in the rat brain using immunohistochemical techniques with a highly specific, affinity-purified, CRT antibody. The results show high levels of CRT localisation is associated with specific brain regions and certain cell types. The CRT is predominantly found in neurones. CRT immunoreactivity is particularly abundant in the olfactory bulb, granule cells of the dentate gyrus of the hippocampus, pyramidal neurones of the cerebral cortex, Purkinje cells of the cerebellum, motor and sensory cranial nerve nuclei in the brainstem and the dorsal and ventral horns of the spinal cord. Low levels of CRT were seen in the basal ganglia and white matter. Overall, CRT was found to show high intensities of labelling in the major motor and sensory regions of the forebrain, brainstem and spinal cord and forebrain regions associated with learning, memory and limbic functions. It is hypothesised that regions with high CRT expression are likely to have high metabolic ATP requirements and that areas with low CRT levels are those regions which are particularly vulnerable in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19580854     DOI: 10.1016/j.neuroscience.2009.06.065

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Downregulation of the creatine transporter SLC6A8 by JAK2.

Authors:  Manzar Shojaiefard; Zohreh Hosseinzadeh; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2012-03-11       Impact factor: 1.843

2.  Expression and distribution of creatine transporter and creatine kinase (brain isoform) in developing and mature rat cochlear tissues.

Authors:  Ann Chi Yan Wong; Sailakshmi Velamoor; Matthew R Skelton; Peter R Thorne; Srdjan M Vlajkovic
Journal:  Histochem Cell Biol       Date:  2012-02-04       Impact factor: 4.304

3.  Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study.

Authors:  Swaantje Casjens; Urike Dydak; Shalmali Dharmadhikari; Anne Lotz; Martin Lehnert; Clara Quetscher; Christoph Stewig; Benjamin Glaubitz; Tobias Schmidt-Wilcke; David Edmondson; Chien-Lin Yeh; Tobias Weiss; Christoph van Thriel; Lennard Herrmann; Siegfried Muhlack; Dirk Woitalla; Michael Aschner; Thomas Brüning; Beate Pesch
Journal:  Neurotoxicology       Date:  2017-08-11       Impact factor: 4.294

Review 4.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

Review 5.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

Review 6.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

Review 7.  Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers.

Authors:  Olivier Braissant
Journal:  J Inherit Metab Dis       Date:  2012-01-18       Impact factor: 4.982

8.  Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.

Authors:  Dae Won Kim; Seong-Il Yeo; Hea Jin Ryu; Ji-Eun Kim; Hong-Ki Song; Oh-Shin Kwon; Soo Young Choi; Tae-Cheon Kang
Journal:  BMC Neurosci       Date:  2010-10-28       Impact factor: 3.288

9.  Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency.

Authors:  Matthew R Skelton; Tori L Schaefer; Devon L Graham; Ton J Degrauw; Joseph F Clark; Michael T Williams; Charles V Vorhees
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

10.  Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect.

Authors:  Jiddeke M van de Kamp; Petra J W Pouwels; Femke K Aarsen; Leontine W ten Hoopen; Dirk L Knol; Johannes B de Klerk; Ireneus F de Coo; Jan G M Huijmans; Cornelis Jakobs; Marjo S van der Knaap; Gajja S Salomons; Grazia M S Mancini
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.